ArticleCurrent oncology (Toronto, Ont.)2021

Identification and In-Depth Analysis of the Novel FGFR2-NDC80 Fusion in a Cholangiocarcinoma Patient: Implication for Therapy.

Alexander Scheiter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.